|
Castejón-Griñán M., Cerdido S., Sánchez-Beltrán J., Lambertos A., Abrisqueta M., Herraiz C., Jiménez-Cervantes C., García-Borrón J.C. Melanoma-associated melanocortin 1 receptor variants confer redox signaling-dependent protection against oxidative DNA damage. Redox Biology. June 2024. 72. 10.1016/j.redox.2024.103135
AÑO: 2024; IF: 11.9
|
|
Cerdido S., Sánchez-Beltrán J., Lambertos A., Abrisqueta M., Padilla L., Herraiz C., Olivares C., Jiménez-Cervantes C., García-Borrón J.C. A Side-by-Side Comparison of Wildtype and Variant Melanocortin 1 Receptor Signaling with Emphasis on Protection against Oxidative Damage to DNA. International Journal of Molecular Sciences. September 2023. 24. 10.3390/ijms241814381
AÑO: 2023; IF: 4.9
|
|
Sirés-Campos J., Lambertos A., Delevoye C., Raposo G., Bennett D.C., Sviderskaya E., Jiménez-Cervantes C., Olivares C., García-Borrón J.C. Mahogunin Ring Finger 1 regulates pigmentation by controlling the pH of melanosomes in melanocytes and melanoma cells. Cellular and Molecular Life Sciences. January 2022. 79. 10.1007/s00018-021-04053-9
AÑO: 2022; IF: 8.0
|
|
Martínez‐vicente I., Abrisqueta M., Herraiz C., Sirés‐campos J., Castejón‐griñán M., Bennett D.C., Olivares C., García‐borrón J.C., Jiménez‐cervantes C. Mahogunin ring finger 1 is required for genomic stability and modulates the malignant phenotype of melanoma cells. Cancers. October 2020. 12:1-23. 10.3390/cancers12102840
AÑO: 2020; IF: 6.639
|
|
Martínez-Vicente I., Abrisqueta M., Herraiz C., Jiménez-Cervantes C., García-Borrón J.C., Olivares C. Functional characterization of a C-terminal splice variant of the human melanocortin 1 receptor. Experimental Dermatology. 1 July 2020. 29:610-615. 10.1111/exd.14118
AÑO: 2020; IF: 3.96
|